Asahi Kasei Therapeutics

Specialty pharmaceutical company

Appears in 1 story · Last updated Oct 16, 2026

Stories

FDA approves first new herpes drug mechanism in nearly 30 years

New Capabilities

Marketing Hovilpri in the United States

The Food and Drug Administration approved Hovilpri (pritelivir) on October 9 for persistent herpes sores in adults with weakened immune systems. It is the first herpes treatment with a new mechanism of action in nearly 30 years.

Updated Oct 16